EI
CLMT icon

EAM Investors’s Calumet Specialty Products CLMT Stock Holding History

EAM Investors’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.7M Sell
102,777
-48,915
-32% -$1.64M 0.33% 140
2026
Q1 		$5.45M Buy
+151,692
New +$3.93M 0.63% 38

Other funds holding CLMT

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WDOM
Wasserstein Debt Opportunities Management New York $264M AUM 188.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

EAM Investors's CLMT Position: Q2 2026 in Review

EAM Investors reduced its Calumet Specialty Products (CLMT) stake by 32% in Q2 2026, selling an estimated $1.64M and leaving 102,777 shares worth $3.7M. The position accounts for 0.33% of the portfolio, ranked #140.

EAM Investors first reported a position in CLMT in Q1 2026 and has held it in 2 quarters since. The position peaked at $5.45M in Q1 2026. 188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • EAM Investors held 102,777 shares of Calumet Specialty Products worth $3.7M as of Q2 2026.
  • EAM Investors sold 48,915 Calumet Specialty Products shares in Q2 2026, an estimated $1.64M.
  • Calumet Specialty Products made up 0.33% of EAM Investors's portfolio in Q2 2026, its #140 holding.
  • EAM Investors first reported a position in Calumet Specialty Products in Q1 2026 and has held it in 2 quarters since.
  • EAM Investors's Calumet Specialty Products position peaked at $5.45M in Q1 2026.
  • 188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on EAM Investors's 13F filing for Q2 2026, filed 13 Aug 2026.